CUSIX
Price
$15.01
Change
-$0.10 (-0.66%)
Updated
Jul 31 closing price
Net Assets
9.55M
DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
Interact to see
Advertisement

CUSIX vs DFSVX

CUSIX vs DFSVX Comparison Chart in %
View a ticker or compare two or three
VS
CUSIX vs. DFSVX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUSIX is a Hold and DFSVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. CUSIX (9.55M). DFSVX pays higher dividends than CUSIX: DFSVX (1.50) vs CUSIX (1.28). CUSIX was incepted earlier than DFSVX: CUSIX (17 years) vs DFSVX (33 years). CUSIX (4.22) is less costly to investors than DFSVX (0.31). CUSIX is a more actively managed with annual turnover of: 38.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than CUSIX: DFSVX (0) vs CUSIX (1000000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. CUSIX (13.06). DFSVX return over 5 years is better than : 50.66 vs. CUSIX (1.90).
CUSIXDFSVXCUSIX / DFSVX
Total Expense Ratio1.000.31323%
Annual Report Gross Expense Ratio4.220.311,361%
Fund Existence17 years33 years-
Gain YTD8.93521.33642%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets9.55M19.5B0%
Annual Yield % from dividends1.281.5085%
Returns for 1 year13.0634.3938%
Returns for 3 years10.5450.3721%
Returns for 5 years1.9050.664%
Returns for 10 years34.61107.7132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I